Monday, October 31, 2022

Monoclonal antibody prevents malaria infection in African adults

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).

 

10/31/2022 08:15 PM EDT

Antibody protected NIH clinical trial participants during six-month malaria season.

This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) · 9000 Rockville Pike · Bethesda MD 20892 · 301-496-4000 / TTY 301-402-9612 GovDelivery logo

No comments:

Post a Comment

Playing the Trump card on shelter limits

Presented by Johnson & Johnson: Kelly Garrity's must-read rundown of what's up on Beacon Hill and beyond...